Risk factors for extreme-drug resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies.

Background: Extreme-drug resistant Pseudomonas aeruginosa (XDRPa) infection has emerged in our hematologic unit and is associated with increased mortality. Treatment options are limited, and infection prevention is currently the best option. We aimed to identify the risk factors for XDRPa infection in patients with hematologic malignancies to facilitate institution of stringent infection control measures.